{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:19:35Z","timestamp":1788941975190,"version":"build-2803163510"},"reference-count":25,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hainan Province Clinical Medical Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Computational and Mathematical Methods in Medicine"],"published-print":{"date-parts":[[2022,5,31]]},"abstract":"<jats:p>\n                    Objective. This study explores the effects of Angiotensin-Converting Enzyme Inhibitors (ACEI) or Angiotensin Receptor Blockers (ARB) on the incidence of end-stage renal disease (ESRD) in diabetic nephropathy (DN) patients. Methods. Literatures were searched in PubMed, Embase, Medline, CENTRAL, and CNKI databases. These literatures included a randomized controlled trial to evaluate the efficacy of ACEI and ARB among patients with DN. The endpoint event included the occurrence of ERSD. Risk ratio (RR) and 95% confidence interval (CI) were used to represent the combined effect size. A fixed-effect model was used to analyze if heterogeneity did not exist between literatures. If heterogeneity exists between literatures, a random-effect model was used to analyze. The source of heterogeneity was explored by subgroup analysis and sensitivity analysis. Results. A total of 11 literatures were included in the study. The RR of ESRD was 0.79 (95% CI (0.79, 0.90),\n                    <jats:inline-formula>\n                      <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>Z<\/a:mi>\n                        <a:mo>=<\/a:mo>\n                        <a:mn>3.58<\/a:mn>\n                      <\/a:math>\n                    <\/jats:inline-formula>\n                    ,\n                    <jats:inline-formula>\n                      <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mi>P<\/c:mi>\n                        <c:mo>=<\/c:mo>\n                        <c:mn>0.0003<\/c:mn>\n                      <\/c:math>\n                    <\/jats:inline-formula>\n                    ) in the patients treated with RAS blockers compared with placebo, and there was no heterogeneity between studies (\n                    <jats:inline-formula>\n                      <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mtext>Ch<\/e:mtext>\n                        <e:msup>\n                          <e:mrow>\n                            <e:mtext>i<\/e:mtext>\n                          <\/e:mrow>\n                          <e:mrow>\n                            <e:mn>2<\/e:mn>\n                          <\/e:mrow>\n                        <\/e:msup>\n                        <e:mo>=<\/e:mo>\n                        <e:mn>5.09<\/e:mn>\n                      <\/e:math>\n                    <\/jats:inline-formula>\n                    ,\n                    <jats:inline-formula>\n                      <g:math xmlns:g=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\">\n                        <g:mi>P<\/g:mi>\n                        <g:mo>=<\/g:mo>\n                        <g:mn>0.88<\/g:mn>\n                      <\/g:math>\n                    <\/jats:inline-formula>\n                    ,\n                    <jats:inline-formula>\n                      <i:math xmlns:i=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M5\">\n                        <i:msup>\n                          <i:mrow>\n                            <i:mi>I<\/i:mi>\n                          <\/i:mrow>\n                          <i:mrow>\n                            <i:mn>2<\/i:mn>\n                          <\/i:mrow>\n                        <\/i:msup>\n                        <i:mo>=<\/i:mo>\n                        <i:mn>0<\/i:mn>\n                        <i:mi>%<\/i:mi>\n                      <\/i:math>\n                    <\/jats:inline-formula>\n                    ). The funnel plot showed that the scatter point was biased to the left with publication bias. The RR of ESRD was 0.63 (95% CI (0.41, 0.95),\n                    <jats:inline-formula>\n                      <k:math xmlns:k=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M6\">\n                        <k:mi>Z<\/k:mi>\n                        <k:mo>=<\/k:mo>\n                        <k:mn>2.18<\/k:mn>\n                      <\/k:math>\n                    <\/jats:inline-formula>\n                    ,\n                    <jats:inline-formula>\n                      <m:math xmlns:m=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M7\">\n                        <m:mi>P<\/m:mi>\n                        <m:mo>=<\/m:mo>\n                        <m:mn>0.03<\/m:mn>\n                      <\/m:math>\n                    <\/jats:inline-formula>\n                    ) in the patients treated with ACEI compared with placebo. There was no heterogeneity between studies (\n                    <jats:inline-formula>\n                      <o:math xmlns:o=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M8\">\n                        <o:mtext>Ch<\/o:mtext>\n                        <o:msup>\n                          <o:mrow>\n                            <o:mtext>i<\/o:mtext>\n                          <\/o:mrow>\n                          <o:mrow>\n                            <o:mn>2<\/o:mn>\n                          <\/o:mrow>\n                        <\/o:msup>\n                        <o:mo>=<\/o:mo>\n                        <o:mn>2.23<\/o:mn>\n                      <\/o:math>\n                    <\/jats:inline-formula>\n                    ,\n                    <jats:inline-formula>\n                      <q:math xmlns:q=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M9\">\n                        <q:mi>P<\/q:mi>\n                        <q:mo>=<\/q:mo>\n                        <q:mn>0.95<\/q:mn>\n                      <\/q:math>\n                    <\/jats:inline-formula>\n                    ,\n                    <jats:inline-formula>\n                      <s:math xmlns:s=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M10\">\n                        <s:msup>\n                          <s:mrow>\n                            <s:mi>I<\/s:mi>\n                          <\/s:mrow>\n                          <s:mrow>\n                            <s:mn>2<\/s:mn>\n                          <\/s:mrow>\n                        <\/s:msup>\n                        <s:mo>=<\/s:mo>\n                        <s:mn>0<\/s:mn>\n                        <s:mi>%<\/s:mi>\n                      <\/s:math>\n                    <\/jats:inline-formula>\n                    ). Compared with placebo, RR of ESRD among patients with ARB intervention was 0.81 (95% CI (0.71, 0.93),\n                    <jats:inline-formula>\n                      <u:math xmlns:u=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M11\">\n                        <u:mi>Z<\/u:mi>\n                        <u:mo>=<\/u:mo>\n                        <u:mn>3.00<\/u:mn>\n                      <\/u:math>\n                    <\/jats:inline-formula>\n                    ,\n                    <jats:inline-formula>\n                      <w:math xmlns:w=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M12\">\n                        <w:mi>P<\/w:mi>\n                        <w:mo>=<\/w:mo>\n                        <w:mn>0.003<\/w:mn>\n                      <\/w:math>\n                    <\/jats:inline-formula>\n                    ). There was no heterogeneity between studies (\n                    <jats:inline-formula>\n                      <y:math xmlns:y=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M13\">\n                        <y:mtext>Ch<\/y:mtext>\n                        <y:msup>\n                          <y:mrow>\n                            <y:mtext>i<\/y:mtext>\n                          <\/y:mrow>\n                          <y:mrow>\n                            <y:mn>2<\/y:mn>\n                          <\/y:mrow>\n                        <\/y:msup>\n                        <y:mo>=<\/y:mo>\n                        <y:mn>1.49<\/y:mn>\n                      <\/y:math>\n                    <\/jats:inline-formula>\n                    ,\n                    <jats:inline-formula>\n                      <ab:math xmlns:ab=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M14\">\n                        <ab:mi>P<\/ab:mi>\n                        <ab:mo>=<\/ab:mo>\n                        <ab:mn>0.48<\/ab:mn>\n                      <\/ab:math>\n                    <\/jats:inline-formula>\n                    ,\n                    <jats:inline-formula>\n                      <cb:math xmlns:cb=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M15\">\n                        <cb:msup>\n                          <cb:mrow>\n                            <cb:mi>I<\/cb:mi>\n                          <\/cb:mrow>\n                          <cb:mrow>\n                            <cb:mn>2<\/cb:mn>\n                          <\/cb:mrow>\n                        <\/cb:msup>\n                        <cb:mo>=<\/cb:mo>\n                        <cb:mn>0<\/cb:mn>\n                        <cb:mi>%<\/cb:mi>\n                      <\/cb:math>\n                    <\/jats:inline-formula>\n                    ). Conclusion. ACEI and ARB can reduce the risk of ESRD among diabetic nephropathy patients.\n                  <\/jats:p>","DOI":"10.1155\/2022\/6962654","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T01:20:13Z","timestamp":1654046413000},"page":"1-6","source":"Crossref","is-referenced-by-count":14,"title":["ACEI and ARB Lower the Incidence of End-Stage Renal Disease among Patients with Diabetic Nephropathy: A Meta-analysis"],"prefix":"10.1155","volume":"2022","author":[{"given":"Xiaojuan","family":"Deng","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Geriatric Hospital of Hainan, Haikou, 571100 Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ling Shui Li Autonomous County People\u2019s Hospital, Lingshui, 572400 Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiufeng","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Geriatric Hospital of Hainan, Haikou, 571100 Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8583-8915","authenticated-orcid":true,"given":"Yueyao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, DanZhou People\u2019s Hospital, Danzhou, 571700 Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.180762"},{"key":"2","first-page":"11","article-title":"Diabetes: type 1 diabetes","volume":"504","author":"M. Pasarica","year":"2021","journal-title":"FP Essent"},{"key":"3","first-page":"22","article-title":"Diabetes: pharmacotherapy for type 2 diabetes","volume":"504","author":"O. E. St","year":"2021","journal-title":"FP Essent"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00194.2020"},{"issue":"2","key":"5","first-page":"38","article-title":"Diabetic nephropathy","volume":"59","author":"M. Kitada","year":"2017","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2021.11.001"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1497449"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2398-8"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i438"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.37970.629537.0D"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)70256-1"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-8-199304150-00001"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2005.00514.x"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(01)00289-3"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2325-z"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011303"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292004"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604113341502"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011489"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01179-8"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61303-8"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)12323-7"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6008"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1303154"}],"container-title":["Computational and Mathematical Methods in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/6962654.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/6962654.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/6962654.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T01:20:17Z","timestamp":1654046417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/cmmm\/2022\/6962654\/"}},"subtitle":[],"editor":[{"given":"Xi","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":25,"alternative-id":["6962654","6962654"],"URL":"https:\/\/doi.org\/10.1155\/2022\/6962654","relation":{},"ISSN":["1748-6718","1748-670X"],"issn-type":[{"value":"1748-6718","type":"electronic"},{"value":"1748-670X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,31]]}}}